Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Total revenues	$ 3,220,000	$ 828,000
Operating expenses (income):
Cost of product revenues	3,458,000	856,000
Research and development	395,000	1,159,000
Change in fair value of contingent consideration	(31,000)	(140,000)
Impairment of property and equipment		210,000
Gain on disposal of property and equipment	(328,000)
Selling, general and administrative	4,349,000	4,069,000
Total operating expenses	7,843,000	6,154,000
Loss from operations	(4,623,000)	(5,326,000)
Interest expense	(1,000)	(9,000)
Other income, net	14,000	7,463,000
Change in fair value of common stock warrant liabilities		322,000
Issuance and offering costs		(769,000)
Net (loss) income before income taxes	(4,610,000)	(1,681,000)
Income tax provision	0
Net (loss) income	(4,610,000)	1,681,000
Net loss attributable to non-controlling interest	(122,000)	(377,000)
Net (loss) income attributable to common stockholders	$ (4,488,000)	$ 2,058,000
Net (loss) income per share attributable to common stockholders:
Basic net (loss) income per share attributable to common stockholders:	$ (0.20)	$ 0.11
Diluted net (loss) income per share attributable to common stockholders:	$ (0.20)	$ 0.11
Denominator:
Weighted average number of common shares outstanding	22,186,993	18,970,250
Weighted average number of common shares outstanding - diluted	22,186,993	19,042,962
Product
Revenues:
Total revenues	$ 3,170,000	$ 803,000
Royalty
Revenues:
Total revenues	$ 50,000	$ 25,000